MicroRNA -196b is related to the overall survival of patients with esophageal squamous cell carcinoma and facilitates tumor progression by regulating SOCS2 (Suppressor Of Cytokine Signaling 2)

References

• Sakai NS, Samia-Aly E, Barbera M, et al. A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol. 2013 23(6):512–521.
   PubMed Web of Science ®Google Scholar
• Yang H, Su H, Hu N, et al. Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis. BMC Cancer. 2020;20(1):1.
   Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7-30.
   Google Scholar
• Fakhrian K, Ordu AD, Lordick F, et al. Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU. Strahlentherapie Und Onkologie. 2014;190(12):1133–1140.
   PubMed Web of Science ®Google Scholar
• Tang WR, Chen ZJ, Lin K, et al. Development of esophageal cancer in Chaoshan region, China: association with environmental, genetic and cultural factors. Int J Hyg Environ Health. 2015;218(1):12–18.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.
   PubMed Web of Science ®Google Scholar
• Chen Q, Hou J, Wu Z, et al. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L. Pathol Res Pract. 2019;215(7):7.
   Web of Science ®Google Scholar
• Roush SF, Slack FJ. Micromanagement: a role for microRNAs in mRNA stability. ACS Chem Biol. 2006;1(3):132–134.
   PubMed Web of Science ®Google Scholar
• dev.m, Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–33
   Google Scholar
• Ohashi S, Miyamoto S, Kikuchi O, et al. Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma. Gastroenterology. 2015;149(7):1700–15
   PubMed Web of Science ®Google Scholar
• Ambs S, Prueitt RL, Yi M, et al. Genomic profiling of microRNA and mRNA reveals deregulated microRNA expression in prostate cancer. other. 2008;68:15.
   Google Scholar
• Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27(34):5848–56.
   PubMed Web of Science ®Google Scholar
• Flynt AS, Lai EC. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Natrevgenet. 2008;9(11):831.
   Web of Science ®Google Scholar
• Zhao Y, Huang J, Chen J. The integration of differentially expressed genes based on multiple microarray datasets for prediction of the prognosis in oral squamous cell carcinoma. cell. 2021 Dec;12(1):3309–3321.
   Google Scholar
• Zhang N, Liu JF. MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN. Bioengineered. 2020 Dec;11(1):972–983.
   PubMed Web of Science ®Google Scholar
• Liu B, Li X, Li C, et al. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling. Bioengineered. 2019;10(1):679–688.
   PubMed Web of Science ®Google Scholar
• Li Y, Li J, Liu Z, et al. High Expression of miR-196b Predicts Poor Prognosis in Patients with Ovarian Cancer. Onco Targets Ther. 2020;13:9797–9806.
   PubMed Web of Science ®Google Scholar
• Li H, Feng C, Shi S. miR-196b promotes lung cancer cell migration and invasion through the targeting of GATA6. Oncol Lett. 2018;16(1):247–252.
   Google Scholar
• Zhao X, Zhang W, Ji W. miR-196b is a prognostic factor of human laryngeal squamous cell carcinoma and promotes tumor progression by targeting SOCS2. Biochem Biophys Res Commun. 2018 Jun 22;501(2):584–592.
   PubMed Web of Science ®Google Scholar
• Yu H, Ding X, Shang L, et al. Protective Ability of Biogenic Antimicrobial Peptide Microcin J25 Against Enterotoxigenic Escherichia Coli-Induced Intestinal Epithelial Dysfunction and Inflammatory Responses IPEC-J2 Cells. Front Cell Infect Microbiol. 2018;8:242.
   PubMed Web of Science ®Google Scholar
• Jing H, Qu X, Liu L, et al. A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer. Med Sci Monit. 2018 Jun 23;24:4317–4323.
   PubMed Web of Science ®Google Scholar
• Han B, Ge Y, Cui J, Liu B. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis. Bioengineered. 2020;11(1):524–535.
   PubMed Web of Science ®Google Scholar
• Zhang H, Peng J, Lai J, et al. MiR-940 promotes malignant progression of breast cancer by regulating FOXO3. Biosci Rep. 2020 Sep 30;40(9):9.
   Google Scholar
• Zhao Z, Liang S, Sun F. LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation. Front Oncol. 2020;10:1172.
   PubMed Web of Science ®Google Scholar
• Lin Y, Totsuka Y, He Y, et al. Epidemiology of Esophageal Cancer in Japan and China. J Epidemiol. 2013;23(4):233.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. Ca A Cancer J Clinicians. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• V?sa U, Vooder TN, Kolde R, et al. Identification of MiR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes Chromosomes & Cancer. 2011;50(10):812–822.
   PubMed Web of Science ®Google Scholar
• Woo LS, Cheol PK, Goo KJ, et al. Dysregulation of MicroRNA-196b-5p and MicroRNA-375 in Gastric Cancer. J Gastric Cancer. 2016;16(4):221–229.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang M, Chen H, et al. Ratio of miR-196s to HOXC8 mRNA Correlates with Breast Cancer Cell Migration and Metastasis. Cancer Res. 2010;70(20):7894–7904.
   PubMed Web of Science ®Google Scholar
• Ge J, Chen Z, Li R, et al. Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer. Cancer Cell Int. 2014;14(1):1–8.
   PubMedGoogle Scholar
• Rebucci M, Sermeus A, Leonard E, et al. miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1. Mol Cancer. 2015 APR 08;14(1):79.
   PubMedGoogle Scholar
• Micevic G, Muthusamy V, Damsky W, et al. DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR. Cell Rep. 2016;14(9):9.
   Web of Science ®Google Scholar
• Braig S, Mueller DW, Rothhammer T, et al. MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cell Mol Life Sci. 2010;67(20):3535–3548.
   PubMed Web of Science ®Google Scholar
• Christine H, Hui ABY, Alajez NM, et al. MicroRNA-196b Regulates the Homeobox B7-Vascular Endothelial Growth Factor Axis in Cervical Cancer. Plos One. 2013;8(7):e67846.
   PubMed Web of Science ®Google Scholar
• Li Y, Li J, Liu Z, et al. High Expression of miR-196b Predicts Poor Prognosis in Patients with Ovarian Cancer. Onco Targets Ther. 2020;8:9797–9806.
   Google Scholar
• Letellier E, Schmitz M, Baig K, et al. Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer. Br J Cancer. 2014 Aug 12;111(4):726–735.
   PubMed Web of Science ®Google Scholar
• Shi LP, Liang M, Li FF, et al. MiR-492 exerts tumor-promoting function in prostate cancer through repressing SOCS2 expression. Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):992–1001.
   PubMed Web of Science ®Google Scholar
• Xu J, Chen Q, Tian K, et al. m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation. Oncol Rep. 2020 Sep;44(3):973–986.
   PubMed Web of Science ®Google Scholar